| Year |
Citation |
Score |
| 2018 |
Fineberg NA, Demetrovics Z, Stein DJ, Ioannidis K, Potenza MN, Grünblatt E, Brand M, Billieux J, Carmi L, King DL, Grant JE, Yücel M, Dell'Osso B, Rumpf HJ, Hall N, ... Hollander E, et al. Manifesto for a European research network into Problematic Usage of the Internet. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 28: 1232-1246. PMID 30509450 DOI: 10.1016/j.euroneuro.2018.08.004 |
0.52 |
|
| 2016 |
Menchón JM, van Ameringen M, Dell'Osso B, Denys D, Figee M, Grant JE, Hollander E, Marazziti D, Nicolini H, Pallanti S, Ruck C, Shavitt R, Stein DJ, Andersson E, Bipeta R, et al. Standards of care for obsessive-compulsive disorder centres. International Journal of Psychiatry in Clinical Practice. 20: 204-208. PMID 27359333 DOI: 10.1080/13651501.2016.1197275 |
1 |
|
| 2016 |
Pallanti S, Marras A, Salerno L, Makris N, Hollander E. Better than treated as usual: Transcranial magnetic stimulation augmentation in selective serotonin reuptake inhibitor-refractory obsessive-compulsive disorder, mini-review and pilot open-label trial. Journal of Psychopharmacology (Oxford, England). PMID 26843373 DOI: 10.1177/0269881116628427 |
1 |
|
| 2016 |
Hunter SF, Agius M, Miller DM, Cutter G, Barbato L, McCague K, Meng X, Agashivala N, Chin P, Hollander E. Impact of a switch to fingolimod on depressive symptoms in patients with relapsing multiple sclerosis: An analysis from the EPOC (Evaluate Patient OutComes) trial Journal of the Neurological Sciences. 365: 190-198. DOI: 10.1016/j.jns.2016.03.024 |
1 |
|
| 2015 |
Grant JE, Fineberg N, van Ameringen M, Cath D, Visser H, Carmi L, Pallanti S, Hollander E, van Balkom AJ. New treatment models for compulsive disorders. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26621260 DOI: 10.1016/j.euroneuro.2015.11.008 |
1 |
|
| 2015 |
Shic F, Smith D, Horsburgh B, Hollander E, Rehg JM, Goodwin M. Catalysts for Change: The Role of Small Business Funders in the Creation and Dissemination of Innovation. Journal of Autism and Developmental Disorders. PMID 26481385 DOI: 10.1007/s10803-015-2636-x |
1 |
|
| 2015 |
Dell'Osso B, Nicolini H, Lanzagorta N, Benatti B, Spagnolin G, Palazzo MC, Marazziti D, Hollander E, Fineberg N, Stein DJ, Pallanti S, Van Ameringen M, Lochner C, Hranov G, Karamustafalioglu O, et al. Cigarette smoking in patients with obsessive compulsive disorder: a report from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS). Cns Spectrums. 1-5. PMID 26349811 DOI: 10.1017/S1092852915000565 |
1 |
|
| 2015 |
Bartz JA, Lydon JE, Kolevzon A, Zaki J, Hollander E, Ludwig N, Bolger N. Differential Effects of Oxytocin on Agency and Communion for Anxiously and Avoidantly Attached Individuals. Psychological Science. 26: 1177-86. PMID 26122122 DOI: 10.1177/0956797615580279 |
1 |
|
| 2015 |
Levkovitz Y, Isserles M, Padberg F, Lisanby SH, Bystritsky A, Xia G, Tendler A, Daskalakis ZJ, Winston JL, Dannon P, Hafez HM, Reti IM, Morales OG, Schlaepfer TE, Hollander E, et al. Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 14: 64-73. PMID 25655160 DOI: 10.1002/wps.20199 |
1 |
|
| 2015 |
Bartz JA, Lydon JE, Kolevzon A, Zaki J, Hollander E, Ludwig N, Bolger N. Differential Effects of Oxytocin on Agency and Communion for Anxiously and Avoidantly Attached Individuals Psychological Science. 26: 1177-1186. DOI: 10.1177/0956797615580279 |
1 |
|
| 2014 |
Lochner C, Fineberg NA, Zohar J, van Ameringen M, Juven-Wetzler A, Altamura AC, Cuzen NL, Hollander E, Denys D, Nicolini H, Dell'Osso B, Pallanti S, Stein DJ. Comorbidity in obsessive-compulsive disorder (OCD): a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS). Comprehensive Psychiatry. 55: 1513-9. PMID 25011690 DOI: 10.1016/j.comppsych.2014.05.020 |
1 |
|
| 2014 |
Van Ameringen M, Simpson W, Patterson B, Dell'Osso B, Fineberg N, Hollander E, Hranov L, Hranov G, Lochner C, Karamustafalioglu O, Marazziti D, Menchon JM, Nicolini H, Pallanti S, Stein DJ, et al. Pharmacological treatment strategies in obsessive compulsive disorder: A cross-sectional view in nine international OCD centers. Journal of Psychopharmacology (Oxford, England). 28: 596-602. PMID 24429223 DOI: 10.1177/0269881113517955 |
1 |
|
| 2014 |
Berlin GS, Hollander E. Compulsivity, impulsivity, and the DSM-5 process Cns Spectrums. 19: 62-68. PMID 24229702 DOI: 10.1017/S1092852913000722 |
1 |
|
| 2014 |
Hirota T, Veenstra-Vanderweele J, Hollander E, Kishi T. Antiepileptic medications in autism spectrum disorder: a systematic review and meta-analysis. Journal of Autism and Developmental Disorders. 44: 948-57. PMID 24077782 DOI: 10.1007/s10803-013-1952-2 |
1 |
|
| 2014 |
Racine E, Kahn T, Hollander E. Compulsive Buying Disorder Behavioral Addictions: Criteria, Evidence, and Treatment. 285-315. DOI: 10.1016/B978-0-12-407724-9.00012-4 |
1 |
|
| 2013 |
King BH, Dukes K, Donnelly CL, Sikich L, McCracken JT, Scahill L, Hollander E, Bregman JD, Anagnostou E, Robinson F, Sullivan L, Hirtz D. Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: a multisite randomized clinical trial. Jama Pediatrics. 167: 1045-52. PMID 24061784 DOI: 10.1001/jamapediatrics.2013.2698 |
1 |
|
| 2013 |
Doyle-Thomas KA, Duerden EG, Taylor MJ, Lerch JP, Soorya LV, Wang AT, Fan J, Hollander E, Anagnostou E. Effects of age and symptomatology on cortical thickness in autism spectrum disorders. Research in Autism Spectrum Disorders. 7: 141-150. PMID 23678367 DOI: 10.1016/j.rasd.2012.08.004 |
1 |
|
| 2013 |
Hallett V, Lecavalier L, Sukhodolsky DG, Cipriano N, Aman MG, McCracken JT, McDougle CJ, Tierney E, King BH, Hollander E, Sikich L, Bregman J, Anagnostou E, Donnelly C, Katsovich L, et al. Exploring the manifestations of anxiety in children with autism spectrum disorders. Journal of Autism and Developmental Disorders. 43: 2341-52. PMID 23400347 DOI: 10.1007/s10803-013-1775-1 |
1 |
|
| 2013 |
Berlin HA, Braun A, Simeon D, Koran LM, Potenza MN, McElroy SL, Fong T, Pallanti S, Hollander E. A double-blind, placebo-controlled trial of topiramate for pathological gambling. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 14: 121-8. PMID 21486110 DOI: 10.3109/15622975.2011.560964 |
1 |
|
| 2012 |
Anagnostou E, Soorya L, Chaplin W, Bartz J, Halpern D, Wasserman S, Wang AT, Pepa L, Tanel N, Kushki A, Hollander E. Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial. Molecular Autism. 3: 16. PMID 23216716 DOI: 10.1186/2040-2392-3-16 |
1 |
|
| 2012 |
Fan J, Bernardi S, Van Dam NT, Anagnostou E, Gu X, Martin L, Park Y, Liu X, Kolevzon A, Soorya L, Grodberg D, Hollander E, Hof PR. Functional deficits of the attentional networks in autism. Brain and Behavior. 2: 647-60. PMID 23139910 DOI: 10.1002/brb3.90 |
1 |
|
| 2012 |
Bandelow B, Sher L, Bunevicius R, Hollander E, Kasper S, Zohar J, Möller HJ. Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care. International Journal of Psychiatry in Clinical Practice. 16: 77-84. PMID 22540422 DOI: 10.3109/13651501.2012.667114 |
1 |
|
| 2012 |
Hollander E, Soorya L, Chaplin W, Anagnostou E, Taylor BP, Ferretti CJ, Wasserman S, Swanson E, Settipani C. A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders. The American Journal of Psychiatry. 169: 292-9. PMID 22193531 DOI: 10.1176/appi.ajp.2011.10050764 |
1 |
|
| 2012 |
Scahill L, McCracken JT, Bearss K, Robinson F, Hollander E, King B, Bregman J, Sikich L, Dukes K, Sullivan L, Anagnostou E, Donnelly C, Kim YS, Ritz L, Hirtz D, et al. Design and subject characteristics in the federally-funded citalopram trial in children with pervasive developmental disorders. Journal of Autism and Developmental Disorders. 42: 432-40. PMID 21667200 DOI: 10.1007/s10803-011-1251-8 |
1 |
|
| 2011 |
Ameis SH, Fan J, Rockel C, Voineskos AN, Lobaugh NJ, Soorya L, Wang AT, Hollander E, Anagnostou E. Impaired structural connectivity of socio-emotional circuits in autism spectrum disorders: a diffusion tensor imaging study. Plos One. 6: e28044. PMID 22132206 DOI: 10.1371/journal.pone.0028044 |
1 |
|
| 2011 |
Girgis RR, Slifstein M, Xu X, Frankle WG, Anagnostou E, Wasserman S, Pepa L, Kolevzon A, Abi-Dargham A, Laruelle M, Hollander E. The 5-HT(2A) receptor and serotonin transporter in Asperger's disorder: A PET study with [¹¹C]MDL 100907 and [¹¹C]DASB. Psychiatry Research. 194: 230-4. PMID 22079057 DOI: 10.1016/j.pscychresns.2011.04.007 |
1 |
|
| 2011 |
Hankin CS, Koran L, Sheehan DV, Hollander E, Culpepper L, Black DW, Knispel J, Dunn J, Dougherty DD, Bronstone A, Wang Z. Patients with obsessive-compulsive disorder vs depression have comparable health care costs: a retrospective claims analysis of Florida Medicaid enrollees. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 23: 285-96. PMID 22073386 |
1 |
|
| 2011 |
Anagnostou E, Chaplin W, Watner D, Silverman JM, Smith CJ, Zagursky K, Kryzak LA, Corwin TE, Feirsen N, Tanel N, Hollander E. Factor analysis of repetitive behaviors in Autism as measured by the Y-BOCS. The Journal of Neuropsychiatry and Clinical Neurosciences. 23: 332-9. PMID 21948895 DOI: 10.1176/appi.neuropsych.23.3.332 |
1 |
|
| 2011 |
Hildebrandt T, Langenbucher JW, Lai JK, Loeb KL, Hollander E. Development and validation of the appearance and performance enhancing drug use schedule. Addictive Behaviors. 36: 949-58. PMID 21640487 DOI: 10.1016/j.addbeh.2011.05.002 |
1 |
|
| 2011 |
Bernardi S, Anagnostou E, Shen J, Kolevzon A, Buxbaum JD, Hollander E, Hof PR, Fan J. In vivo 1H-magnetic resonance spectroscopy study of the attentional networks in autism. Brain Research. 1380: 198-205. PMID 21185269 DOI: 10.1016/j.brainres.2010.12.057 |
1 |
|
| 2011 |
Bartz J, Simeon D, Hamilton H, Kim S, Crystal S, Braun A, Vicens V, Hollander E. Oxytocin can hinder trust and cooperation in borderline personality disorder. Social Cognitive and Affective Neuroscience. 6: 556-63. PMID 21115541 DOI: 10.1093/scan/nsq085 |
1 |
|
| 2011 |
Berlin HA, Koran LM, Jenike MA, Shapira NA, Chaplin W, Pallanti S, Hollander E. Double-blind, placebo-controlled trial of topiramate augmentation in treatment-resistant obsessive-compulsive disorder. The Journal of Clinical Psychiatry. 72: 716-21. PMID 20816027 DOI: 10.4088/JCP.09m05266gre |
1 |
|
| 2011 |
Morgenstern J, Muench F, O'Leary A, Wainberg M, Parsons JT, Hollander E, Blain L, Irwin T. Non-paraphilic compulsive sexual behavior and psychiatric co-morbidities in gay and bisexual men Sexual Addiction and Compulsivity. 18: 114-134. DOI: 10.1080/10720162.2011.593420 |
1 |
|
| 2010 |
Bartz JA, Zaki J, Bolger N, Hollander E, Ludwig NN, Kolevzon A, Ochsner KN. Oxytocin selectively improves empathic accuracy. Psychological Science. 21: 1426-8. PMID 20855907 DOI: 10.1177/0956797610383439 |
1 |
|
| 2010 |
Pallanti S, Haznedar MM, Hollander E, Licalzi EM, Bernardi S, Newmark R, Buchsbaum MS. Basal Ganglia activity in pathological gambling: a fluorodeoxyglucose-positron emission tomography study. Neuropsychobiology. 62: 132-8. PMID 20588072 DOI: 10.1159/000317286 |
1 |
|
| 2010 |
Phillips KA, Stein DJ, Rauch SL, Hollander E, Fallon BA, Barsky A, Fineberg N, Mataix-Cols D, Ferrão YA, Saxena S, Wilhelm S, Kelly MM, Clark LA, Pinto A, Bienvenu OJ, et al. Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V? Depression and Anxiety. 27: 528-55. PMID 20533367 DOI: 10.1002/da.20705 |
1 |
|
| 2010 |
Hollander E, Stein DJ, Fineberg NA, Marteau F, Legault M. Quality of life outcomes in patients with obsessive-compulsive disorder: relationship to treatment response and symptom relapse. The Journal of Clinical Psychiatry. 71: 784-92. PMID 20492845 DOI: 10.4088/JCP.09m05911blu |
1 |
|
| 2010 |
Leckman JF, Denys D, Simpson HB, Mataix-Cols D, Hollander E, Saxena S, Miguel EC, Rauch SL, Goodman WK, Phillips KA, Stein DJ. Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V. Depression and Anxiety. 27: 507-27. PMID 20217853 DOI: 10.1002/da.20669 |
1 |
|
| 2010 |
Kolevzon A, Newcorn JH, Kryzak L, Chaplin W, Watner D, Hollander E, Smith CJ, Cook EH, Silverman JM. Relationship between whole blood serotonin and repetitive behaviors in autism. Psychiatry Research. 175: 274-6. PMID 20044143 DOI: 10.1016/j.psychres.2009.02.008 |
1 |
|
| 2010 |
Hollander E, Chaplin W, Soorya L, Wasserman S, Novotny S, Rusoff J, Feirsen N, Pepa L, Anagnostou E. Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disorders. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 990-8. PMID 20010551 DOI: 10.1038/npp.2009.202 |
1 |
|
| 2010 |
Fineberg NA, Potenza MN, Chamberlain SR, Berlin HA, Menzies L, Bechara A, Sahakian BJ, Robbins TW, Bullmore ET, Hollander E. Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 591-604. PMID 19940844 DOI: 10.1038/npp.2009.185 |
1 |
|
| 2010 |
Pallanti S, Bernardi S, Allen A, Hollander E. Serotonin function in pathological gambling: blunted growth hormone response to sumatriptan. Journal of Psychopharmacology (Oxford, England). 24: 1802-9. PMID 19825906 DOI: 10.1177/0269881109106907 |
0.4 |
|
| 2010 |
Pallanti S, Bernardi S, Allen A, Chaplin W, Watner D, DeCaria CM, Hollander E. Noradrenergic function in pathological gambling: blunted growth hormone response to clonidine. Journal of Psychopharmacology (Oxford, England). 24: 847-53. PMID 19028836 DOI: 10.1177/0269881108099419 |
1 |
|
| 2009 |
Hankin CS, Koran LM, Bronstone A, Black DW, Sheehan DV, Hollander E, Dunn JD, Culpepper L, Knispel J, Dougherty DD, Wang Z. Adequacy of pharmacotherapy among medicaid-enrolled patients newly diagnosed with obsessive-compulsive disorder. Cns Spectrums. 14: 695-703. PMID 20394177 |
1 |
|
| 2009 |
Stein DJ, Denys D, Gloster AT, Hollander E, Leckman JF, Rauch SL, Phillips KA. Obsessive-compulsive disorder: diagnostic and treatment issues. The Psychiatric Clinics of North America. 32: 665-85. PMID 19716996 DOI: 10.1016/j.psc.2009.05.007 |
1 |
|
| 2009 |
King BH, Hollander E, Sikich L, McCracken JT, Scahill L, Bregman JD, Donnelly CL, Anagnostou E, Dukes K, Sullivan L, Hirtz D, Wagner A, Ritz L. Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. Archives of General Psychiatry. 66: 583-90. PMID 19487623 DOI: 10.1001/archgenpsychiatry.2009.30 |
1 |
|
| 2009 |
Smith CJ, Lang CM, Kryzak L, Reichenberg A, Hollander E, Silverman JM. Familial associations of intense preoccupations, an empirical factor of the restricted, repetitive behaviors and interests domain of autism. Journal of Child Psychology and Psychiatry, and Allied Disciplines. 50: 982-90. PMID 19298470 DOI: 10.1111/j.1469-7610.2009.02060.x |
1 |
|
| 2009 |
Hälbig TD, Tse W, Frisina PG, Baker BR, Hollander E, Shapiro H, Tagliati M, Koller WC, Olanow CW. Subthalamic deep brain stimulation and impulse control in Parkinson's disease. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 16: 493-7. PMID 19236471 DOI: 10.1111/j.1468-1331.2008.02509.x |
1 |
|
| 2008 |
Hollander E, Abramowitz JS, Koran LM, Pallanti S. Obsessive-compulsive disorder: Strategies for optimal treatment Journal of Clinical Psychiatry. 69: 1647-1657. PMID 19192448 |
1 |
|
| 2008 |
Bandelow B, Zohar J, Hollander E, Kasper S, Möller HJ, Zohar J, Hollander E, Kasper S, Möller HJ, Bandelow B, Allgulander C, Ayuso-Gutierrez J, Baldwin DS, Buenvicius R, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 9: 248-312. PMID 18949648 DOI: 10.1080/15622970802465807 |
1 |
|
| 2008 |
Hollander E, Buchsbaum MS, Haznedar MM, Berenguer J, Berlin HA, Chaplin W, Goodman CR, LiCalzi EM, Newmark R, Pallanti S. FDG-PET study in pathological gamblers. 1. Lithium increases orbitofrontal, dorsolateral and cingulate metabolism. Neuropsychobiology. 58: 37-47. PMID 18781089 DOI: 10.1159/000154478 |
1 |
|
| 2008 |
Berlin HA, Hamilton H, Hollander E. Experimental therapeutics for refractory obsessive-compulsive disorder: translational approaches and new somatic developments. The Mount Sinai Journal of Medicine, New York. 75: 174-203. PMID 18704978 DOI: 10.1002/msj.20045 |
1 |
|
| 2008 |
Bartz JA, Hollander E. Oxytocin and experimental therapeutics in autism spectrum disorders Progress in Brain Research. 170: 451-462. PMID 18655901 DOI: 10.1016/S0079-6123(08)00435-4 |
1 |
|
| 2008 |
Parikh MS, Kolevzon A, Hollander E. Psychopharmacology of aggression in children and adolescents with autism: a critical review of efficacy and tolerability. Journal of Child and Adolescent Psychopharmacology. 18: 157-78. PMID 18439113 DOI: 10.1089/cap.2007.0041 |
0.4 |
|
| 2008 |
Gotham K, Risi S, Dawson G, Tager-Flusberg H, Joseph R, Carter A, Hepburn S, McMahon W, Rodier P, Hyman SL, Sigman M, Rogers S, Landa R, Spence MA, Osann K, ... ... Hollander E, et al. A replication of the Autism Diagnostic Observation Schedule (ADOS) revised algorithms. Journal of the American Academy of Child and Adolescent Psychiatry. 47: 642-51. PMID 18434924 DOI: 10.1097/CHI.0b013e31816bffb7 |
1 |
|
| 2008 |
Trivedi MH, Hollander E, Nutt D, Blier P. Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression Journal of Clinical Psychiatry. 69: 246-258. PMID 18363453 |
1 |
|
| 2008 |
Dell'Osso B, Allen A, Altamura AC, Buoli M, Hollander E. Impulsive-compulsive buying disorder: clinical overview. The Australian and New Zealand Journal of Psychiatry. 42: 259-66. PMID 18330768 DOI: 10.1080/00048670701881561 |
0.4 |
|
| 2008 |
Dell'Osso B, Hadley S, Allen A, Baker B, Chaplin WF, Hollander E. Escitalopram in the treatment of impulsive-compulsive internet usage disorder: an open-label trial followed by a double-blind discontinuation phase. The Journal of Clinical Psychiatry. 69: 452-6. PMID 18312057 |
1 |
|
| 2008 |
Allen A, Hadley SJ, Kaplan A, Simeon D, Friedberg J, Priday L, Baker BR, Greenberg JL, Hollander E. An open-label trial of venlafaxine in body dysmorphic disorder. Cns Spectrums. 13: 138-44. PMID 18227745 |
1 |
|
| 2008 |
Silverman JM, Buxbaum JD, Ramoz N, Schmeidler J, Reichenberg A, Hollander E, Angelo G, Smith CJ, Kryzak LA. Autism-related routines and rituals associated with a mitochondrial aspartate/glutamate carrier SLC25A12 polymorphism. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 147: 408-10. PMID 17894412 DOI: 10.1002/ajmg.b.30614 |
1 |
|
| 2008 |
Bartz JA, Young LJ, Hollander E, Buxbaum JD, Ring RH. Preclinical animal models of autistic spectrum disorders (ASD) Animal and Translational Models For Cns Drug Discovery. 1: 353-394. DOI: 10.1016/B978-0-12-373861-5.00011-4 |
1 |
|
| 2007 |
Buxbaum JD, Cai G, Nygren G, Chaste P, Delorme R, Goldsmith J, RÃ¥stam M, Silverman JM, Hollander E, Gillberg C, Leboyer M, Betancur C. Mutation analysis of the NSD1 gene in patients with autism spectrum disorders and macrocephaly. Bmc Medical Genetics. 8: 68. PMID 18001468 DOI: 10.1186/1471-2350-8-68 |
1 |
|
| 2007 |
Koran LM, Hanna GL, Hollander E, Nestadt G, Simpson HB. Practice guideline for the treatment of patients with obsessive-compulsive disorder. The American Journal of Psychiatry. 164: 5-53. PMID 17849776 |
1 |
|
| 2007 |
Simeon D, Baker B, Chaplin W, Braun A, Hollander E. An open-label trial of divalproex extended-release in the treatment of borderline personality disorder. Cns Spectrums. 12: 439-43. PMID 17545954 |
1 |
|
| 2007 |
Josephson SC, Hollander E, Sumner J. Comprehensive treatment of three patients with comorbid OCPD and ADHD Cns Spectrums. 12: 338-342. PMID 17514078 DOI: 10.1017/S1092852900021131 |
1 |
|
| 2007 |
Buxbaum JD, Cai G, Chaste P, Nygren G, Goldsmith J, Reichert J, Anckarsäter H, Rastam M, Smith CJ, Silverman JM, Hollander E, Leboyer M, Gillberg C, Verloes A, Betancur C. Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 144: 484-91. PMID 17427195 DOI: 10.1002/ajmg.b.30493 |
1 |
|
| 2007 |
Szatmari P, Paterson AD, Zwaigenbaum L, Roberts W, Brian J, Liu XQ, Vincent JB, Skaug JL, Thompson AP, Senman L, Feuk L, Qian C, Bryson SE, Jones MB, ... ... Hollander E, et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nature Genetics. 39: 319-28. PMID 17322880 DOI: 10.1038/ng1985 |
1 |
|
| 2007 |
Simeon D, Knutelska M, Smith L, Baker BR, Hollander E. A preliminary study of cortisol and norepinephrine reactivity to psychosocial stress in borderline personality disorder with high and low dissociation. Psychiatry Research. 149: 177-84. PMID 17169436 DOI: 10.1016/j.psychres.2005.11.014 |
1 |
|
| 2007 |
Hollander E, Bartz J, Chaplin W, Phillips A, Sumner J, Soorya L, Anagnostou E, Wasserman S. Oxytocin increases retention of social cognition in autism. Biological Psychiatry. 61: 498-503. PMID 16904652 DOI: 10.1016/j.biopsych.2006.05.030 |
1 |
|
| 2007 |
Muench F, Morgenstern J, Hollander E, Irwin T, O'Leary A, Parsons JT, Wainberg ML, Lai B. The consequences of compulsive sexual behavior: The preliminary reliability and validity of the compulsive sexual behavior consequences scale Sexual Addiction and Compulsivity. 14: 207-220. DOI: 10.1080/10720160701480493 |
1 |
|
| 2007 |
Hollander E. The Neuropsychiatry of the Parietal Lobe: Clinical Manifestations of Integrated Neural Networks in Everyday Practice Cns Spectrums. 12: 504-504. DOI: 10.1017/S1092852900021222 |
0.36 |
|
| 2006 |
Wainberg ML, Muench F, Morgenstern J, Hollander E, Irwin TW, Parsons JT, Allen A, O'Leary A. A double-blind study of citalopram versus placebo in the treatment of compulsive sexual behaviors in gay and bisexual men. The Journal of Clinical Psychiatry. 67: 1968-73. PMID 17194276 DOI: 10.4088/JCP.v67n1218 |
1 |
|
| 2006 |
Pallanti S, Bernardi S, Quercioli L, DeCaria C, Hollander E. Serotonin dysfunction in pathological gamblers: increased prolactin response to oral m-CPP versus placebo. Cns Spectrums. 11: 956-64. PMID 17146409 DOI: 10.1017/S1092852900015145 |
0.52 |
|
| 2006 |
Sakurai T, Ramoz N, Reichert JG, Corwin TE, Kryzak L, Smith CJ, Silverman JM, Hollander E, Buxbaum JD. Association analysis of the NrCAM gene in autism and in subsets of families with severe obsessive-compulsive or self-stimulatory behaviors. Psychiatric Genetics. 16: 251-7. PMID 17106428 DOI: 10.1097/01.ypg.0000242196.81891.c9 |
1 |
|
| 2006 |
Hollander E, Wasserman S, Swanson EN, Chaplin W, Schapiro ML, Zagursky K, Novotny S. A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder. Journal of Child and Adolescent Psychopharmacology. 16: 541-8. PMID 17069543 DOI: 10.1089/cap.2006.16.541 |
1 |
|
| 2006 |
Wasserman S, Iyengar R, Chaplin WF, Watner D, Waldoks SE, Anagnostou E, Soorya L, Hollander E. Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study. International Clinical Psychopharmacology. 21: 363-7. PMID 17012983 DOI: 10.1097/01.yic.0000224787.13782.0f |
1 |
|
| 2006 |
Ramoz N, Cai G, Reichert JG, Corwin TE, Kryzak LA, Smith CJ, Silverman JM, Hollander E, Buxbaum JD. Family-based association study of TPH1 and TPH2 polymorphisms in autism. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 141: 861-7. PMID 16958027 DOI: 10.1002/ajmg.b.30356 |
1 |
|
| 2006 |
Bartz JA, Hollander E. The neuroscience of affiliation: forging links between basic and clinical research on neuropeptides and social behavior. Hormones and Behavior. 50: 518-28. PMID 16884725 DOI: 10.1016/j.yhbeh.2006.06.018 |
1 |
|
| 2006 |
Anagnostou E, Esposito K, Soorya L, Chaplin W, Wasserman S, Hollander E. Divalproex versus placebo for the prevention of irritability associated with fluoxetine treatment in autism spectrum disorder. Journal of Clinical Psychopharmacology. 26: 444-6. PMID 16855475 DOI: 10.1097/01.jcp.0000227703.72117.bc |
1 |
|
| 2006 |
Haznedar MM, Buchsbaum MS, Hazlett EA, LiCalzi EM, Cartwright C, Hollander E. Volumetric analysis and three-dimensional glucose metabolic mapping of the striatum and thalamus in patients with autism spectrum disorders. The American Journal of Psychiatry. 163: 1252-63. PMID 16816232 DOI: 10.1176/appi.ajp.163.7.1252 |
1 |
|
| 2006 |
Buchsbaum MS, Hollander E, Pallanti S, Baldini Rossi N, Platholi J, Newmark R, Bloom R, Sood E. Positron emission tomography imaging of risperidone augmentation in serotonin reuptake inhibitor-refractory patients. Neuropsychobiology. 53: 157-68. PMID 16707915 DOI: 10.1159/000093342 |
1 |
|
| 2006 |
Kolevzon A, Mathewson KA, Hollander E. Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability. The Journal of Clinical Psychiatry. 67: 407-14. PMID 16649827 DOI: 10.4088/JCP.V67N0311 |
1 |
|
| 2006 |
Bartz JA, Hollander E. Is obsessive-compulsive disorder an anxiety disorder? Progress in Neuro-Psychopharmacology and Biological Psychiatry. 30: 338-352. PMID 16455175 DOI: 10.1016/j.pnpbp.2005.11.003 |
1 |
|
| 2006 |
Rosario-Campos MC, Miguel EC, Quatrano S, Chacon P, Ferrao Y, Findley D, Katsovich L, Scahill L, King RA, Woody SR, Tolin D, Hollander E, Kano Y, Leckman JF. The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions. Molecular Psychiatry. 11: 495-504. PMID 16432526 DOI: 10.1038/sj.mp.4001798 |
1 |
|
| 2006 |
Hollander E, Soorya L, Wasserman S, Esposito K, Chaplin W, Anagnostou E. Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 9: 209-13. PMID 16316486 DOI: 10.1017/S1461145705005791 |
1 |
|
| 2005 |
Hollander E, Pallanti S, Baldini Rossi N, Sood E, Baker BR, Buchsbaum MS. Imaging monetary reward in pathological gamblers. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 6: 113-20. PMID 16156484 DOI: 10.1080/15622970510029768 |
1 |
|
| 2005 |
Hollander E, Anagnostou E, Chaplin W, Esposito K, Haznedar MM, Licalzi E, Wasserman S, Soorya L, Buchsbaum M. Striatal volume on magnetic resonance imaging and repetitive behaviors in autism. Biological Psychiatry. 58: 226-32. PMID 15939406 DOI: 10.1016/j.biopsych.2005.03.040 |
1 |
|
| 2005 |
Hollander E, Phillips A, Chaplin W, Zagursky K, Novotny S, Wasserman S, Iyengar R. A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 582-9. PMID 15602505 DOI: 10.1038/sj.npp.1300627 |
1 |
|
| 2005 |
Costa P, Samuels J, Bagby M, Daffin L, Norton H, Gabbard GO, Rothenberg A, Shapiro D, Serpell L, Hirani V, Hollander E, Sharma L, Hand I, Fricke S, Nestadt G, et al. Obsessive-Compulsive Personality Disorder: A Review Personality Disorders. 405-477. DOI: 10.1002/0470090383.ch6 |
1 |
|
| 2004 |
Novotny S, Hollander E, Phillips A, Allen A, Wasserman S, Iyengar R. Increased repetitive behaviours and prolactin responsivity to oral m-chlorophenylpiperazine in adults with autism spectrum disorders. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 7: 249-54. PMID 15132762 DOI: 10.1017/S146114570400433X |
0.4 |
|
| 2004 |
Hazlett EA, Buchsbaum MS, Hsieh P, Haznedar MM, Platholi J, LiCalzi EM, Cartwright C, Hollander E. Regional glucose metabolism within cortical Brodmann areas in healthy individuals and autistic patients. Neuropsychobiology. 49: 115-25. PMID 15034226 DOI: 10.1159/000076719 |
1 |
|
| 2004 |
Hollander E, Phillips A, King BH, Guthrie D, Aman MG, Law P, Owley T, Robinson R. Impact of recent findings on study design of future autism clinical trials. Cns Spectrums. 9: 49-56. PMID 14999175 DOI: 10.1017/S109285290000835X |
1 |
|
| 2004 |
Buxbaum JD, Silverman J, Keddache M, Smith CJ, Hollander E, Ramoz N, Reichert JG. Linkage analysis for autism in a subset families with obsessive-compulsive behaviors: evidence for an autism susceptibility gene on chromosome 1 and further support for susceptibility genes on chromosome 6 and 19. Molecular Psychiatry. 9: 144-50. PMID 14699429 DOI: 10.1038/sj.mp.4001465 |
1 |
|
| 2003 |
Simeon D, Greenberg J, Knutelska M, Schmeidler J, Hollander E. Peritraumatic reactions associated with the World Trade Center disaster American Journal of Psychiatry. 160: 1702-1705. PMID 12944351 DOI: 10.1176/appi.ajp.160.9.1702 |
1 |
|
| 2003 |
Johnson SM, Hollander E. Evidence that eicosapentaenoic acid is effective in treating autism. The Journal of Clinical Psychiatry. 64: 848-9. PMID 12934990 DOI: 10.4088/JCP.V64N0718C |
1 |
|
| 2002 |
Silverman JM, Smith CJ, Schmeidler J, Hollander E, Lawlor BA, Fitzgerald M, Buxbaum JD, Delaney K, Galvin P. Symptom domains in autism and related conditions: evidence for familiality. American Journal of Medical Genetics. 114: 64-73. PMID 11840508 DOI: 10.1002/ajmg.10048 |
1 |
|
| 2001 |
Simeon D, Guralnik O, Knutelska M, Hollander E, Schmeidler J. Hypothalamic-pituitary-adrenal axis dysregulation in depersonalization disorder Neuropsychopharmacology. 25: 793-795. PMID 11682263 DOI: 10.1016/S0893-133X(01)00288-3 |
1 |
|
| 2001 |
Buchsbaum MS, Hollander E, Haznedar MM, Tang C, Spiegel-Cohen J, Wei TC, Solimando A, Buchsbaum BR, Robins D, Bienstock C, Cartwright C, Mosovich S. Effect of fluoxetine on regional cerebral metabolism in autistic spectrum disorders: a pilot study. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 4: 119-25. PMID 11466160 DOI: doi:10.1017/S1461145701002280 |
1 |
|
| 2001 |
Hollander E, Allen A, Lopez RP, Bienstock CA, Grossman R, Siever LJ, Merkatz L, Stein DJ. A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder. The Journal of Clinical Psychiatry. 62: 199-203. PMID 11305707 DOI: 10.4088/JCP.V62N0311 |
0.52 |
|
| 2000 |
Haznedar MM, Buchsbaum MS, Wei TC, Hof PR, Cartwright C, Bienstock CA, Hollander E. Limbic circuitry in patients with autism spectrum disorders studied with positron emission tomography and magnetic resonance imaging. The American Journal of Psychiatry. 157: 1994-2001. PMID 11097966 DOI: 10.1176/appi.ajp.157.12.1994 |
1 |
|
| 2000 |
Simeon D, Guralnik O, Hazlett EA, Spiegel-Cohen J, Hollander E, Buchsbaum MS. Feeling unreal: a PET study of depersonalization disorder. The American Journal of Psychiatry. 157: 1782-8. PMID 11058475 DOI: 10.1176/appi.ajp.157.11.1782 |
1 |
|
| 2000 |
Hollander E, Buchalter AJ, DeCaria CM. Pathological gambling. The Psychiatric Clinics of North America. 23: 629-42. PMID 10986732 DOI: 10.1016/s0193-953x(05)70185-4 |
1 |
|
| 2000 |
Novotny S, Hollander E, Allen A, Mosovich S, Aronowitz B, Cartwright C, DeCaria C, Dolgoff-Kaspar R. Increased growth hormone response to sumatriptan challenge in adult autistic disorders. Psychiatry Research. 94: 173-7. PMID 10808042 DOI: 10.1016/S0165-1781(00)00134-7 |
0.52 |
|
| 2000 |
Hollander E, Novotny S, Allen A, Aronowitz B, Cartwright C, DeCaria C. The relationship between repetitive behaviors and growth hormone response to sumatriptan challenge in adult autistic disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 22: 163-7. PMID 10649829 DOI: 10.1016/S0893-133X(99)00121-9 |
0.32 |
|
| 2000 |
Cohen LJ, Kingston P, Bell A, Kwon J, Aronowitz B, Hollander E. Comorbid personality impairment in body dysmorphic disorder. Comprehensive Psychiatry. 41: 4-12. PMID 10646612 DOI: 10.1016/S0010-440X(00)90124-X |
1 |
|
| 1999 |
Hollander E, DelGiudice-Asch G, Simon L, Schmeidler J, Cartwright C, DeCaria CM, Kwon J, Cunningham-Rundles C, Chapman F, Zabriskie JB. B lymphocyte antigen D8/17 and repetitive behaviors in autism. The American Journal of Psychiatry. 156: 317-20. PMID 9989573 DOI: 10.1176/ajp.156.2.317 |
0.4 |
|
| 1999 |
Rauch SL, Benkelfat C, Dager SR, Greenberg BD, Hendler T, Hollander E, Laruelle M, Rosenberg DR, Saxena S, Zohar J, Baxter L.R. J. Neuroimaging research and neurocircuitry models of obsessive-compulsive disorder: Proceedings of the Third IOCDC Cns Spectrums. 4: 25-34. |
1 |
|
| 1998 |
Simeon D, Stein DJ, Hollander E. Treatment of depersonalization disorder with clomipramine. Biological Psychiatry. 44: 302-3. PMID 9715363 DOI: 10.1016/S0006-3223(98)00023-7 |
0.4 |
|
| 1997 |
Haznedar MM, Buchsbaum MS, Metzger M, Solimando A, Spiegel-Cohen J, Hollander E. Anterior cingulate gyrus volume and glucose metabolism in autistic disorder. The American Journal of Psychiatry. 154: 1047-50. PMID 9247387 DOI: 10.1176/AJP.154.8.1047 |
1 |
|
| 1997 |
Josephson SC, Hollander E. Body dysmorphic disorder by proxy Journal of Clinical Psychiatry. 58: 86-87. PMID 9062380 |
1 |
|
| 1997 |
Simeon D, Cohen LJ, Stein DJ, Schmeidler J, Spadaccini E, Hollander E. Comorbid self-injurious behaviors in 71 female hair-pullers: a survey study. The Journal of Nervous and Mental Disease. 185: 117-9. PMID 9048705 DOI: 10.1097/00005053-199702000-00009 |
0.32 |
|
| 1997 |
Cohen LJ, Stein D, Galynker I, Hollander E. Towards an integration of psychological and biological models of obsessive-compulsive disorder: Phylogenetic considerations Cns Spectrums. 2: 26-44. |
1 |
|
| 1996 |
Wong CM, Hollander E. Headache response to m-chlorophenylpiperazine in obsessive-compulsive disorder and normal controls Biological Psychiatry. 40: 544-546. PMID 8879476 DOI: 10.1016/0006-3223(96)00164-3 |
1 |
|
| 1995 |
Skodol AE, Oldham JM, Hyler SE, Stein DJ, Hollander E, Gallaher PE, Lopez AE. Patterns of anxiety and personality disorder comorbidity Journal of Psychiatric Research. 29: 361-374. PMID 8748061 DOI: 10.1016/0022-3956(95)00015-W |
1 |
|
| 1995 |
Stein DJ, Spadaccini E, Hollander E. Meta-analysis of pharmacotherapy trials for obsessive-compulsive disorder. International Clinical Psychopharmacology. 10: 11-8. PMID 7622800 DOI: 10.1097/00004850-199503000-00002 |
0.4 |
|
| 1994 |
Stein DJ, Hollander E, Chan S, DeCaria CM, Hilal S, Liebowitz MR, Klein DF. Computed tomography and neurological soft signs in obsessive-compulsive disorder. Psychiatry Research. 50: 143-50. PMID 8272450 DOI: 10.1016/0925-4927(93)90026-E |
0.52 |
|
| 1994 |
Stein DJ, Hollander E, Cohen L, Frenkel M, Saoud JB, DeCaria C, Aronowitz B, Levin A, Liebowitz MR, Cohen L. Neuropsychiatric impairment in impulsive personality disorders. Psychiatry Research. 48: 257-66. PMID 8272447 DOI: 10.1016/0165-1781(93)90076-S |
0.32 |
|
| 1994 |
Stein DJ, Keating J, Zar HJ, Hollander E. A survey of the phenomenology and pharmacotherapy of compulsive and impulsive-aggressive symptoms in Prader-Willi syndrome. The Journal of Neuropsychiatry and Clinical Neurosciences. 6: 23-9. PMID 8148633 DOI: 10.1176/JNP.6.1.23 |
0.36 |
|
| 1994 |
Stein DJ, Dodman NH, Borchelt P, Hollander E. Behavioral disorders in veterinary practice: relevance to psychiatry. Comprehensive Psychiatry. 35: 275-85. PMID 7956183 DOI: 10.1016/0010-440X(94)90019-1 |
0.44 |
|
| 1994 |
Aronowitz B, Liebowitz M, Hollander E, Fazzini E, Durlach-Misteli C, Frenkel M, Mosovich S, Garfinkel R, Saoud J, DelBene D, Cohen L, Jaeger A, Rubin AL. Neuropsychiatric and neuropsychological findings in conduct disorder and attention-deficit hyperactivity disorder Journal of Neuropsychiatry and Clinical Neurosciences. 6: 245-249. PMID 7950346 DOI: 10.1176/JNP.6.3.245 |
1 |
|
| 1994 |
Towey JP, Tenke CE, Bruder GE, Leite P, Friedman D, Liebowitz M, Hollander E. Brain event-related potential correlates of overfocused attention in obsessive-compulsive disorder Psychophysiology. 31: 535-543. PMID 7846214 DOI: 10.1111/j.1469-8986.1994.tb02346.x |
1 |
|
| 1993 |
Prichep LS, Mas F, Hollander E, Liebowitz M, John ER, Almas M, DeCaria CM, Levine RH. Quantitative electroencephalographic subtyping of obsessive-compulsive disorder. Psychiatry Research. 50: 25-32. PMID 8511221 DOI: 10.1016/0925-4927(93)90021-9 |
1 |
|
| 1993 |
Stein DJ, Hutt CS, Spitz JL, Hollander E. Compulsive picking and obsessive-compulsive disorder. Psychosomatics. 34: 177-81. PMID 8456163 DOI: 10.1016/S0033-3182(93)71911-8 |
0.56 |
|
| 1993 |
Hollander E, Stein DJ, DeCaria CM, Saoud JB, Klein DF, Liebowitz MR. A pilot study of biological predictors of treatment outcome in obsessive-compulsive disorder. Biological Psychiatry. 33: 747-9. PMID 8353170 DOI: 10.1016/0006-3223(93)90126-X |
0.48 |
|
| 1993 |
Hollander E, Cohen LJ, DeCaria C, Saoud JB, Stein DJ, Cooper TB, Islam NN, Liebowitz MR, Klein DF. Timing of neuroendocrine responses and effect of m-CPP and fenfluramine plasma levels in OCD. Biological Psychiatry. 34: 407-13. PMID 8218609 DOI: 10.1016/0006-3223(93)90186-H |
0.48 |
|
| 1993 |
Towey J, Bruder G, Tenke C, Leite P, DeCaria C, Friedman D, Hollander E. Event-related potential and clinical correlates of neurodysfunction in obsessive-compulsive disorder Psychiatry Research. 49: 167-181. PMID 8153189 DOI: 10.1016/0165-1781(93)90103-N |
1 |
|
| 1993 |
Papp LA, Klein DF, Martinez J, Schneier F, Cole R, Liebowitz MR, Hollander E, Fyer AJ, Jordan F, Gorman JM. Diagnostic and substance specificity of carbon-dioxide-induced panic. The American Journal of Psychiatry. 150: 250-7. PMID 8123056 DOI: 10.1176/AJP.150.2.250 |
1 |
|
| 1993 |
Stein DJ, Hollander E, Liebowitz MR. Neurobiology of impulsivity and the impulse control disorders. The Journal of Neuropsychiatry and Clinical Neurosciences. 5: 9-17. PMID 7679020 DOI: 10.1176/JNP.5.1.9 |
0.6 |
|
| 1993 |
Hollander E, Stein DJ, Saoud JB, DeCaria CM, Cooper TB, Islam MN, Liebowitz MR, Stanley M. Effects of fenfluramine on plasma homovanillic acid in healthy subjects. Journal of Neural Transmission. General Section. 90: 81-4. PMID 1466879 DOI: 10.1007/BF01250520 |
0.4 |
|
| 1993 |
Stein DJ, Hollander E. Impulsive Aggression and Obsessive-Compulsive Disorder Psychiatric Annals. 23: 389-395. DOI: 10.3928/0048-5713-19930701-10 |
0.32 |
|
| 1993 |
Stein DJ, Hollander E, Skodol AE. Anxiety Disorders and Personality Disorders: A Review Journal of Personality Disorders. 7: 87-104. DOI: 10.1521/PEDI.1993.7.2.87 |
0.4 |
|
| 1992 |
Hollander E, DeCaria CM, Aronowitz B, Klein DF, Liebowitz MR, Shaffer D. A pilot follow-up study of childhood soft signs and the development of adult psychopathology. The Journal of Neuropsychiatry and Clinical Neurosciences. 3: 186-9. PMID 1821234 DOI: 10.1176/JNP.3.2.186 |
0.44 |
|
| 1992 |
Hollander E, DeCaria CM, Nitescu A, Gully R, Suckow RF, Cooper TB, Gorman JM, Klein DF, Liebowitz MR. Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers. Archives of General Psychiatry. 49: 21-8. PMID 1728249 DOI: 10.1001/ARCHPSYC.1992.01820010021003 |
0.44 |
|
| 1992 |
Stein DJ, Shoulberg N, Helton K, Hollander E. The neuroethological approach to obsessive-compulsive disorder. Comprehensive Psychiatry. 33: 274-81. PMID 1643870 DOI: 10.1016/0010-440X(92)90053-S |
0.6 |
|
| 1992 |
Hollander E, Stein DJ, Saoud JB, DeCaria CM, Cooper TB, Trungold S, Stanley M, Liebowitz MR. Effects of fenfluramine on plasma HVA in OCD. Psychiatry Research. 42: 185-8. PMID 1631253 DOI: 10.1016/0165-1781(92)90081-D |
1 |
|
| 1992 |
Fallon BA, Campeas R, Schneier FR, Hollander E, Feerick J, Hatterer J, Goetz D, Davies S, Liebowitz MR. Open trial of intravenous clomipramine in five treatment-refractory patients with obsessive-compulsive disorder. The Journal of Neuropsychiatry and Clinical Neurosciences. 4: 70-5. PMID 1627966 DOI: 10.1176/JNP.4.1.70 |
1 |
|
| 1992 |
Hollander E, Frenkel M, Decaria C, Trungold S, Stein DJ. Treatment of pathological gambling with clomipramine. The American Journal of Psychiatry. 149: 710-1. PMID 1575267 DOI: 10.1176/AJP.149.5.710B |
1 |
|
| 1992 |
Liebowitz MR, Schneier F, Campeas R, Hollander E, Hatterer J, Fyer A, Gorman J, Papp L, Davies S, Gully R. Phenelzine vs atenolol in social phobia. A placebo-controlled comparison. Archives of General Psychiatry. 49: 290-300. PMID 1558463 DOI: 10.1001/ARCHPSYC.49.4.290 |
1 |
|
| 1992 |
Stein DJ, Hollander E. Dermatology and conditions related to obsessive-compulsive disorder. Journal of the American Academy of Dermatology. 26: 237-42. PMID 1552059 DOI: 10.1016/0190-9622(92)70033-C |
0.4 |
|
| 1992 |
Schneier FR, Chin SJ, Hollander E, Liebowitz MR. Fluoxetine in social phobia. Journal of Clinical Psychopharmacology. 12: 62-4. PMID 1552041 DOI: 10.1097/00001573-199202000-00020 |
1 |
|
| 1992 |
Hollander E, Carrasco JL, Mullen LS, Trungold S, DeCaria CM, Towey J. Left hemispheric activation in depersonalization disorder: a case report. Biological Psychiatry. 31: 1157-62. PMID 1525279 DOI: 10.1016/0006-3223(92)90161-R |
1 |
|
| 1992 |
Hollander E, Stein DJ, Decaria CM, Cohen L, Islam M, Frenkel M. Disorders related to OCD--neurobiology. Clinical Neuropharmacology. 259A-260A. PMID 1498832 DOI: 10.1097/00002826-199201001-00135 |
0.4 |
|
| 1991 |
Hollander E, DeCaria C, Gully R, Nitescu A, Suckow RF, Gorman JM, Klein DF, Liebowitz MR. Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine in obsessive-compulsive disorder. Psychiatry Research. 36: 1-17. PMID 2017519 DOI: 10.1016/0165-1781(91)90113-4 |
0.56 |
|
| 1991 |
Hollander E, DeCaria C, Nitescu A, Cooper T, Stover B, Gully R, Klein DF, Liebowitz MR. Noradrenergic function in obsessive-compulsive disorder: behavioral and neuroendocrine responses to clonidine and comparison to healthy controls. Psychiatry Research. 37: 161-77. PMID 1876628 DOI: 10.1016/0165-1781(91)90073-X |
0.44 |
|
| 1990 |
Hatterer JA, Gorman JM, Fyer AJ, Campeas RB, Schneier FR, Hollander E, Papp LA, Liebowitz MR. Pharmacotherapy of four men with paruresis. The American Journal of Psychiatry. 147: 109-11. PMID 2403470 DOI: 10.1176/AJP.147.1.109 |
1 |
|
| 1990 |
Towey J, Bruder G, Hollander E, Friedman D, Erhan H, Liebowitz M, Sutton S. Endogenous event-related potentials in obsessive-compulsive disorder Biological Psychiatry. 28: 92-98. PMID 2378924 DOI: 10.1016/0006-3223(90)90626-D |
1 |
|
| 1990 |
Hollander E, Liebowitz MR, DeCaria C, Klein DF. Fenfluramine, cortisol, and anxiety. Psychiatry Research. 31: 211-3. PMID 2360951 DOI: 10.1016/0165-1781(90)90124-N |
0.64 |
|
| 1990 |
Schneier FR, Liebowitz MR, Davies SO, Fairbanks J, Hollander E, Campeas R, Klein DF. Fluoxetine in panic disorder. Journal of Clinical Psychopharmacology. 10: 119-21. PMID 2341585 DOI: 10.1097/00004714-199004000-00007 |
1 |
|
| 1990 |
Liebowitz MR, Hollander E, Fairbanks J, Campeas R. Fluoxetine for adolescents with obsessive-compulsive disorder. The American Journal of Psychiatry. 147: 370-1. PMID 2309962 DOI: 10.1176/AJP.147.3.370B |
0.48 |
|
| 1990 |
Hollander E, Schiffman E, Cohen B, Rivera-Stein MA, Rosen W, Gorman JM, Fyer AJ, Papp L, Liebowitz MR. Signs of central nervous system dysfunction in obsessive-compulsive disorder. Archives of General Psychiatry. 47: 27-32. PMID 2294853 DOI: 10.1001/ARCHPSYC.1990.01810130029005 |
0.8 |
|
| 1990 |
Liebowitz MR, Hollander E, Schneier F, Campeas R, Welkowitz L, Hatterer J, Fallon B. Reversible and irreversible monoamine oxidase inhibitors in other psychiatric disorders. Acta Psychiatrica Scandinavica. Supplementum. 360: 29-34. PMID 2248064 DOI: 10.1111/j.1600-0447.1990.tb05321.x |
1 |
|
| 1990 |
Hollander E, Neville D, DeCaria C, Mullen L, Schneier FR, Liebowitz MR. On dysmorphophobia misdiagnosed as obsessive-compulsive disorder. Psychosomatics. 31: 468-9. PMID 2247582 DOI: 10.1016/S0033-3182(90)72157-3 |
1 |
|
| 1990 |
Liebowitz MR, Hollander E, Schneier F, Campeas R, Fallon B, Welkowitz L, Cloitre M, Davies S. Anxiety and depression: discrete diagnostic entities? Journal of Clinical Psychopharmacology. 10: 61S-66S. PMID 2198302 |
1 |
|
| 1989 |
Hollander E, Papp L, Campeas R, DeCaria C, Liebowitz MR. More on self mutilation and obsessive compulsive disorder. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 33: 675. PMID 3058294 DOI: 10.1177/070674378803300728 |
0.56 |
|
| 1989 |
Liebowitz MR, Hollander E. Lactate-induced anxiety. Biological Psychiatry. 25: 669-70. PMID 2923929 DOI: 10.1016/0006-3223(89)90235-7 |
0.6 |
|
| 1989 |
Hollander E, Liebowitz MR, Gorman JM, Cohen B, Fyer A, Klein DF. Cortisol and sodium lactate-induced panic. Archives of General Psychiatry. 46: 135-40. PMID 2913972 DOI: 10.1001/ARCHPSYC.1989.01810020037007 |
0.6 |
|
| 1989 |
Hollander E, Fairbanks J, Decaria C, Liebowitz MR. Pharmacological dissection of panic and depersonalization. The American Journal of Psychiatry. 146: 402. PMID 2784040 DOI: 10.1176/AJP.146.3.402 |
0.52 |
|
| 1989 |
Hollander E, Liebowitz MR, Cohen B, Gorman JM, Fyer AJ, Papp LA, Klein DF. Prolactin and sodium lactate-induced panic. Psychiatry Research. 28: 181-91. PMID 2748770 DOI: 10.1016/0165-1781(89)90046-2 |
0.4 |
|
| 1989 |
Hollander E, Liebowitz MR, Winchel R, Klumker A, Klein DF. Treatment of body-dysmorphic disorder with serotonin reuptake blockers. The American Journal of Psychiatry. 146: 768-70. PMID 2658627 DOI: 10.1176/AJP.146.6.768 |
0.64 |
|
| 1989 |
Papp LA, Goetz R, Cole R, Klein DF, Jordan F, Liebowitz MR, Fyer AJ, Hollander E, Gorman JM. Hypersensitivity to carbon dioxide in panic disorder. The American Journal of Psychiatry. 146: 779-81. PMID 2499198 DOI: 10.1176/AJP.146.6.779 |
0.32 |
|
| 1988 |
Hollander E, Liebowitz MR. Augmentation of antiobsessional treatment with fenfluramine. The American Journal of Psychiatry. 145: 1314-5. PMID 3138920 DOI: 10.1176/AJP.145.10.1314A |
0.48 |
|
| 1988 |
Liebowitz MR, Fyer AJ, Gorman JM, Campeas RB, Sandberg DP, Hollander E, Papp LA, Klein DF. Tricyclic therapy of the DSM-III anxiety disorders: a review with implications for further research. Journal of Psychiatric Research. 7-31. PMID 3050060 DOI: 10.1016/0022-3956(88)90067-2 |
0.6 |
|
| 1988 |
FYER AJ, LIEBOWITZ MR, GORMAN JM, CAMPEAS R, LEVIN A, SANDBERG D, FYER M, HOLLANDER E, PAPP L, GOETZ D, KLEIN DF. Effects of Clonidine on Alprazolam Discontinuation in Panic Patients Journal of Clinical Psychopharmacology. 8: 270???274. DOI: 10.1097/00004714-198808000-00006 |
0.32 |
|
| 1987 |
Davidson M, Mohs RC, Hollander E, Zemishlany Z, Powchik P, Ryan T, Davis KL. Lecithin and piracetam in Alzheimer's disease. Biological Psychiatry. 22: 112-4. PMID 3790634 DOI: 10.1016/0006-3223(87)90139-9 |
1 |
|
| 1987 |
Liebowitz MR, Campeas R, Hollander E. MAOIs: impact on social behavior. Psychiatry Research. 22: 89-90. PMID 3659222 DOI: 10.1016/0165-1781(87)90054-0 |
0.44 |
|
| 1987 |
Hollander E, Davidson M, Mohs RC, Horvath TB, Davis BM, Zemishlany Z, Davis KL. RS 86 in the treatment of Alzheimer's disease: cognitive and biological effects. Biological Psychiatry. 22: 1067-78. PMID 3651528 DOI: 10.1016/0006-3223(87)90049-7 |
1 |
|
| 1987 |
Davis KL, Hollander E, Davidson M, Davis BM, Mohs RC, Horvath TB. Induction of depression with oxotremorine in patients with Alzheimer's disease. The American Journal of Psychiatry. 144: 468-71. PMID 3565616 DOI: 10.1176/AJP.144.4.468 |
1 |
|
| 1986 |
Davidson M, Kendler KS, Mohs RC, Hollander E, Ryan T, Davis KL. Effect of apomorphine infusion on plasma homovanillic acid in normal subjects. Journal of Psychiatric Research. 20: 131-5. PMID 3735141 DOI: 10.1016/0022-3956(86)90012-9 |
1 |
|
| 1986 |
Hollander E, Mohs RC, Davis KL. Antemortem markers of Alzheimer's disease. Neurobiology of Aging. 7: 367-407. PMID 3537824 DOI: 10.1016/0197-4580(86)90164-8 |
1 |
|
| 1986 |
Hollander E, Mohs RC, Davis KL. Cholinergic approaches to the treatment of Alzheimer's disease. British Medical Bulletin. 42: 97-100. PMID 3006861 DOI: 10.1093/OXFORDJOURNALS.BMB.A072106 |
1 |
|
| Show low-probability matches. |